Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BOLA2P1 (BolA family member 2 pseudogene 1) is a processed pseudogene in the human genome, meaning it is a DNA sequence similar to the BOLA2 gene but contains disabling mutations, preventing it from encoding a functional BolA protein. Like many pseudogenes, BOLA2P1 does not have protein-coding potential and is generally considered nonfunctional; however, pseudogenes can sometimes regulate the expression of related genes through RNA-based mechanisms, such as acting as competing endogenous RNAs or sources of small interfering RNAs[1][4]. There is no evidence BOLA2P1 is directly involved in disease or clinical therapy, nor does it serve as a therapeutic target or biomarker. Its potential biological impact, if any, would most likely be through subtle modulation of gene expression or as a source of genetic variation, common features of some pseudogenes[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BolA family member 2 pseudogene 1 (BOLA2P1).